Delivery Order HHSN272201700020I-75N93024F00002
Award Date 7/12/24
Potential Completion Date 7/11/25
Potential Value $1.9M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Taiwan
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Pharmacology Discovery Services Taiwan, LTD. was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. The $754,505.00 firm fixed price delivery order funds the provision of murine (mouse) models of bacterial infections to support NIAID's infectious disease research program. This includes...
- This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Pharmacology Discovery Services Taiwan, Ltd., a for-profit Taiwanese company. The contract, valued at $1,239,019.00, is a delivery order issued under NIAID's Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. Under this delivery order, Pharmacology Discovery...
- This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Pharmacology Discovery Services Taiwan, Ltd., a Taiwanese for-profit organization. The contract, valued at $1,797,620.00, is a delivery order issued under the larger NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity contract vehicle. Under this contract,...
- This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Pharmacology Discovery Services Taiwan, Ltd., a for-profit Taiwanese company that provides preclinical disease modeling services. The $506,429.00 delivery order is for the development and testing of murine (mouse) models of lung infections caused by antibiotic-resistant Pseudomonas aeruginosa bacteria, to support...
- Pharmacology Discovery Services Taiwan, LTD. was awarded a $1,187,770 firm fixed price delivery order against the National Institute of Allergy and Infectious Diseases Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity contract. The delivery order is for therapeutic testing in murine models of bacterial thigh, lung, and peritonitis infections to support the National Institute of Allergy and Infectious Diseases' pre-clinical research mission. Work will...
- Pharmacology Discovery Services Taiwan, LTD. was awarded a $1,747,930 firm fixed price delivery order against the National Institute of Allergy and Infectious Diseases (NIAID) Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity contract. The delivery order is for pre-clinical models of infectious diseases to support therapeutic testing in murine models of bacterial infection, as described in the original solicitation. Work will be performed in Taiwan...
- Pharmacology Discovery Services Taiwan, LTD. was awarded a $1,170,062.04 delivery order against the National Institute of Allergy and Infectious Diseases (NIAID) Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity contract. This delivery order funds the prime contractor's work providing preclinical disease modeling services to support NIAID's infectious disease research mission. Specifically, Pharmacology Discovery Services Taiwan will supply murine and...
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $332,878 delivery order to Pharmacology Discovery Services Taiwan, LTD under the NIAID Preclinical Models of Infectious Diseases 2017-2024 master IDIQ. This cost-plus-award-fee contract will provide pre-clinical models of infectious diseases to support research efforts at NIAID through September 1, 2021. As part of its mission to conduct and support research on infectious, immunologic, and...
- Pharmacology Discovery Services Taiwan, LTD. was awarded a $336,528 delivery order against the National Institute of Allergy and Infectious Diseases (NIAID) Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity contract. The delivery order is for the company to supply murine models of urinary tract infections caused by antibiotic-resistant bacteria, in support of NIAID's major program focused on preclinical research of infectious disease mechanisms and...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1.89 million delivery order to Pharmacology Discovery Services Taiwan, LTD. on July 15, 2024, for the development of murine models of urinary tract infections caused by antibiotic-resistant bacteria. This delivery order falls under the Pre-Clinical Models of Infectious Diseases indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle, which carries a ceiling value of $146.3 million and extends through July...
- HHSN272201700020IIndefinite Delivery Contract
- HHSN272201700020I-75N93024F00002Delivery Order
This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Pharmacology Discovery Services Taiwan, LTD., a Taiwanese for-profit company. The $1,872,088.00 firm fixed price delivery order is part of the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. Under this delivery order, Pharmacology Discovery Services Taiwan will provide NIAID with a mouse model of Neisseria gonorrhoeae infection to support the agency's infectious disease research mission. The contract has a performance period ending on July 11, 2025 and was awarded on July 12, 2024. No set-aside designation was used for this award.
Generated 3/20/25, 9:45 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 3/19/25 | |
| Not listed | Not listed | $331.3k | 7/11/24 |